Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 1, 2022.
Article Versions
- Latest version (July 15, 2022 - 04:00).
- You are currently viewing a Latest version of this article (October 1, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Chanakya Kodishala,
- Cassondra A. Hulshizer,
- Vanessa L. Kronzer,
- John M. Davis III,
- Vijay K. Ramanan,
- Maria Vassilaki,
- Michelle M. Mielke,
- Cynthia S. Crowson and
- Elena Myasoedova
- This work was supported by grants from the National Institutes of Health (NIH), National Institute on Aging (NIA; R01 AG068192, R01 AG034676), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR46849). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, collection, analysis, or interpretation of data, or writing or submitting the manuscript.
C. Kodishala, MBBS, DM, V.L. Kronzer, MD, MSCI, J.M. Davis III, MD, Division of Rheumatology, Mayo Clinic; C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic; V.K. Ramanan, MD, PhD, Department of Neurology, Mayo Clinic; M. Vassilaki, MD, PhD, Department of Quantitative Health Sciences, Mayo Clinic; M.M. Mielke, PhD, Department of Quantitative Health Sciences, Department of Neurology, Mayo Clinic; C.S. Crowson, PhD, Division of Rheumatology, Department of Quantitative Health Sciences, Mayo Clinic; E. Myasoedova, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
JMD has received a research grant from Pfizer. MV has received research funding from F. Hoffmann-La Roche and Biogen; consultant fees from F. Hoffmann-La Roche; research funding from NIA; and has equity ownership in Abbott, Johnson and Johnson, Medtronic, and Amgen. MMM has received consultant fees from Biogen, Brain Protection Company, and LabCorp; and research funding from the NIH and Department of Defense.
All other authors declare no conflicts of interest relevant to this article.
Address correspondence to Dr. E. Myasoedova, 200 First Street SW, Rochester, MN 55905, USA. Email: Myasoedova.elena@mayo.edu.
Accepted for publication June 30, 2022.